177 related articles for article (PubMed ID: 15121658)
1. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.
Schildkraut JJ; Mooney JJ
Am J Psychiatry; 2004 May; 161(5):909-11. PubMed ID: 15121658
[TBL] [Abstract][Full Text] [Related]
2. Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).
Mooney JJ; Samson JA; Hennen J; Pappalardo K; McHale N; Alpert J; Koutsos M; Schildkraut JJ
J Psychiatr Res; 2008 Jul; 42(8):605-11. PubMed ID: 17727882
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells.
Horvath G; Sutto Z; Torbati A; Conner GE; Salathe M; Wanner A
Am J Physiol Lung Cell Mol Physiol; 2003 Oct; 285(4):L829-37. PubMed ID: 12807698
[TBL] [Abstract][Full Text] [Related]
5. Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
Bowman MA; Mitchell NC; Owens WA; Horton RE; Koek W; Daws LC;
Eur J Pharmacol; 2020 Sep; 883():173285. PubMed ID: 32697958
[TBL] [Abstract][Full Text] [Related]
6. [The role of glial monoamine transporters in the central nervous system].
Inazu M; Takeda H; Matsumiya T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):171-8. PubMed ID: 13677912
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
Page ME; Lucki I
Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
[TBL] [Abstract][Full Text] [Related]
8. The neuropharmacology of serotonin and noradrenaline in depression.
Nutt DJ
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
[TBL] [Abstract][Full Text] [Related]
9. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
[TBL] [Abstract][Full Text] [Related]
10. The localisation of the extraneuronal monoamine transporter (EMT) in rat brain.
Haag C; Berkels R; Gründemann D; Lazar A; Taubert D; Schömig E
J Neurochem; 2004 Jan; 88(2):291-7. PubMed ID: 14690517
[TBL] [Abstract][Full Text] [Related]
11. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH
Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250
[TBL] [Abstract][Full Text] [Related]
12. [Domino principle--monoamines in bottom-view].
Sümegi A
Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel, inhibitory action of amiodarone on vesicular monoamine transport.
Haikerwal D; Dart AM; Little PJ; Kaye DM
J Pharmacol Exp Ther; 1999 Feb; 288(2):834-7. PubMed ID: 9918596
[TBL] [Abstract][Full Text] [Related]
14. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
Am J Psychiatry; 1967 Nov; 124(5):600-8. PubMed ID: 4383104
[No Abstract] [Full Text] [Related]
16. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.
Rahman Z; Ring RH; Young K; Platt B; Lin Q; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Brain Res; 2008 Apr; 1203():68-78. PubMed ID: 18321472
[TBL] [Abstract][Full Text] [Related]
17. Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney DS
J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
[TBL] [Abstract][Full Text] [Related]
18. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
Lorez HP
Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
[No Abstract] [Full Text] [Related]
19. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
[TBL] [Abstract][Full Text] [Related]
20. Plasma normetanephrine for examination of extraneuronal uptake and metabolism of noradrenaline in rats.
Eisenhofer G
Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):259-69. PubMed ID: 8208304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
